Unichem Laboratories Ltd

₹ 383 -1.49%
03 Oct - close price
About

Unichem Laboratories Ltd is involved in pharmaceuticals
in Generics, APIs and Contract Manufacturing (CMO) areas.[1]

Key Points

Therapeutic Areas
The company manufactures a wide range of APIs and pharmaceutical formulations as branded and simple generics. Its products cater to diverse range of therapeutic areas, such as cardiology, gastroenterology, diabetology, psychiatry, neurology and others. [1]

  • Market Cap 2,702 Cr.
  • Current Price 383
  • High / Low 414 / 198
  • Stock P/E 128
  • Book Value 372
  • Dividend Yield 1.05 %
  • ROCE 0.89 %
  • ROE 1.22 %
  • Face Value 2.00

Pros

  • Stock is trading at 1.03 times its book value
  • Company has been maintaining a healthy dividend payout of 40.2%

Cons

  • Tax rate seems low
  • Company has a low return on equity of -0.36% over last 3 years.
  • Earnings include an other income of Rs.39.6 Cr.
  • Debtor days have increased from 115 to 142 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022
273 268 275 290 317 318 326 274 298 291 311 370 310
294 295 292 277 305 288 296 255 300 284 313 302 311
Operating Profit -20 -27 -17 13 12 30 30 19 -2 6 -1 68 -1
OPM % -7% -10% -6% 5% 4% 9% 9% 7% -1% 2% -0% 18% -0%
26 28 26 12 17 10 16 8 16 3 15 14 8
Interest 1 2 2 2 1 1 1 2 1 2 1 2 3
Depreciation 18 21 19 23 21 21 21 22 22 22 23 23 25
Profit before tax -14 -22 -13 0 7 18 23 3 -9 -16 -11 58 -21
Tax % 55% -3% -9% 4,007% 65% 51% -0% 114% -27% 17% -24% -23% -13%
Net Profit -6 -22 -15 -17 2 9 24 -0 -11 -13 -14 71 -23
EPS in Rs -0.88 -3.15 -2.07 -2.44 0.35 1.24 3.35 -0.06 -1.63 -1.82 -2.00 10.15 -3.32
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 TTM
824 875 1,081 1,133 1,202 1,333 698 815 1,180 1,104 1,235 1,270 1,282
677 757 906 956 1,100 1,169 738 942 1,254 1,153 1,144 1,198 1,209
Operating Profit 148 118 174 178 101 164 -41 -128 -74 -49 91 72 72
OPM % 18% 14% 16% 16% 8% 12% -6% -16% -6% -4% 7% 6% 6%
11 10 13 83 20 15 184 2,735 91 91 50 47 40
Interest 2 4 3 3 3 3 3 8 8 8 5 6 8
Depreciation 29 30 38 46 41 39 44 51 67 82 84 91 94
Profit before tax 127 94 146 212 77 137 97 2,548 -58 -48 51 22 10
Tax % 25% 24% 22% 20% 3% 21% -12% 0% 59% -25% 33% -50%
Net Profit 95 71 113 169 75 108 109 2,545 -24 -60 34 33 21
EPS in Rs 10.53 7.89 12.52 18.68 8.31 11.90 11.96 361.82 -3.38 -8.55 4.87 4.70 3.01
Dividend Payout % 38% 38% 36% 43% 24% 17% 25% 1% -118% -47% 82% 85%
Compounded Sales Growth
10 Years: 4%
5 Years: 13%
3 Years: 2%
TTM: 5%
Compounded Profit Growth
10 Years: -8%
5 Years: -22%
3 Years: 40%
TTM: 4%
Stock Price CAGR
10 Years: 8%
5 Years: 9%
3 Years: 29%
1 Year: 39%
Return on Equity
10 Years: 18%
5 Years: 20%
3 Years: 0%
Last Year: 1%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
18 18 18 18 18 18 18 14 14 14 14 14
Reserves 600 642 709 798 849 936 1,045 2,666 2,606 2,517 2,543 2,604
51 46 27 26 22 36 98 151 200 206 119 349
213 280 318 302 264 283 359 359 323 407 436 351
Total Liabilities 881 987 1,073 1,145 1,153 1,274 1,521 3,190 3,142 3,145 3,112 3,319
377 408 448 419 416 403 491 578 810 870 884 990
CWIP 63 113 132 91 123 237 250 238 92 330 568 494
Investments 21 15 39 11 41 14 14 901 926 550 392 264
420 451 454 623 574 620 766 1,473 1,313 1,395 1,269 1,571
Total Assets 881 987 1,073 1,145 1,153 1,274 1,521 3,190 3,142 3,145 3,112 3,319

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
69 124 171 87 78 112 68 -112 -328 20 33 -260
-48 -102 -118 36 -52 -85 -132 1,648 -286 -36 -66 100
-29 -14 -51 -95 -51 -33 59 -881 -2 -62 -121 191
Net Cash Flow -8 8 1 28 -25 -7 -4 655 -616 -78 -154 32

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Debtor Days 82 76 70 63 58 60 165 124 135 129 74 142
Inventory Days 199 183 132 192 171 184 397 278 278 374 518 527
Days Payable 145 162 145 142 114 131 297 230 182 236 202 161
Cash Conversion Cycle 135 97 57 113 116 113 265 172 231 267 390 508
Working Capital Days 98 81 59 95 89 94 225 200 227 217 194 277
ROCE % 20% 14% 20% 19% 9% 15% 9% 128% -2% -2% 2% 1%

Shareholding Pattern

Numbers in percentages

Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022
50.62 50.62 50.74 50.93 50.93 50.93 50.93 50.93 50.93 50.93 50.93 50.93
1.92 1.89 1.76 1.61 1.59 1.55 1.50 1.54 1.53 1.45 1.47 1.50
8.37 9.37 9.46 9.23 9.18 9.08 8.94 9.09 9.09 9.30 9.59 9.53
39.09 38.12 38.04 38.23 38.29 38.44 38.62 38.43 38.44 38.32 38.01 38.04

Documents